A case of carcinosarcoma of uterine endometrium associated with Tamoxifen use in breast cancer patient / 대한산부인과학회잡지
Korean Journal of Obstetrics and Gynecology
;
: 1236-1240, 2002.
Artículo
en Coreano
| WPRIM
| ID: wpr-87498
ABSTRACT
Tamoxifen, which is often used in breast cancer therapy, has also been used in the treatment of patients with advanced and recurrent endometrial carcinoma. Tamoxifen has been shown to have significant benificial effects in the treatment of breast cancer patients as hormonal therapy. However, there is evidence that tamoxifen may affect other hormone sensitive organs, including the uterus and ovaries. An increased risk of endometrial polyps, endometrial hyperplasia and endometrial cancer has been reported in tamoxifen treated women. We are able to make this report because we have experienced uterine endometrial carcinosarcoma which is developed in a patient treated with tamoxifen for five years following a modified radical mastectomy due to breast cancer in our hospital.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Ovario
/
Pólipos
/
Tamoxifeno
/
Útero
/
Mama
/
Neoplasias de la Mama
/
Carcinosarcoma
/
Mastectomía Radical Modificada
/
Neoplasias Endometriales
/
Hiperplasia Endometrial
Límite:
Femenino
/
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Obstetrics and Gynecology
Año:
2002
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS